Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis
Open Access
- 6 October 2013
- journal article
- Published by Springer Nature in Critical Care
- Vol. 17 (5) , R223
Abstract
Introduction: Reduced monocyte human leukocyte antigen (mHLA)-DR surface expression in the late phase of sepsis is postulated as a general biomarker of sepsis-induced immunosuppression and an independent predictor of nosocomial infections. However, traditional monitoring of mHLA-DR by flow cytometry has disadvantages due to specific laboratory requirements. An mRNA-based HLA-DR monitoring by polymerase chain reaction (PCR) would improve the clinical usage and facilitate conduction of large multicenter studies. In this study, we evaluated an mRNA-based HLA-DR monitoring by quantitative real-time PCR (qRT-PCR) as an alternative method to traditional flow cytometry. Methods: Fifty-nine patients with sepsis and blood culture growing pathogenic bacteria were studied. Blood samples were collected at day 1 or 2 after admission, for measurement of mHLA-DR by flow cytometry and mRNA expression of HLA-DRA and class II transactivator (CIITA) by qRT-PCR. Blood samples from blood donors were used as controls (n = 30). Results: A significant reduced expression of mHLA-DR, HLA-DRA, and CIITA was seen in septic patients compared with controls. HLA-DRA mRNA level in whole blood was highly correlated with surface expression of mHLA-DR. Conclusions: Patients with sepsis display a diminished expression of HLA-DR at the monocyte surface as well as in the gene expression at the mRNA level. The mRNA expression level of HLA-DRA monitored by qRT-PCR correlates highly with surface expression of HLA-DR and appears to be a possible future biomarker for evaluation of immunosuppression in sepsis.Keywords
This publication has 29 references indexed in Scilit:
- Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?American Journal of Respiratory and Critical Care Medicine, 2013
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachThe Lancet Infectious Diseases, 2013
- Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shockIntensive Care Medicine, 2010
- Immunotherapy for Sepsis — A New Approach against an Ancient FoeNew England Journal of Medicine, 2010
- The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisIntensive Care Medicine, 2010
- Sepsis: Time has come to focus on the later stagesMedical Hypotheses, 2008
- Monitoring Temporary Immunodepression by Flow Cytometric Measurement of Monocytic HLA-DR Expression: A Multicenter Standardized StudyClinical Chemistry, 2005
- Monocyte Human Leukocyte Antigen–DR Transcriptional Downregulation by Cortisol during Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Role of Interleukin-10 in the Intracellular Sequestration of Human Leukocyte Antigen-DR in Monocytes during Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Monocyte deactivation-rationale for a new therapeutic strategy in sepsisIntensive Care Medicine, 1996